SPP 1738 © All rights reserved. Sign in
Falkenried 94 20251 Hamburg Germany
Phone : +49(0)40 7410 56615
Fax : +49(0)40 7410 56598
E-Mail : email@example.com
Web : See online here
Multiple sclerosis (MS) is the most frequent inflammatory disease of the central nervous system (CNS). Inflammatory insults lead to progressive degeneration of axons and neurons that are key for the development of permanent neurological disability. While it is clear that inflammation contributes to neuronal stress responses resulting in mitochondrial dysfunction and energy depletion, it remains ill defined which factors stabilise these response networks. Regulation by microRNAs (miRNAs) is an important mechanism of regulating translational activity and stability of mRNAs during stress responses. Therefore, we aim at understanding how the changes of neuronal gene expression during inflammation are regulated by miRNAs and whether this regulation impacts on protein expression that are critical for mitochondrial function thereby reinforcing or ameliorating neurodegeneration. Accordingly, the first necessary step in the characterisation of the role of miRNAs in inflammation-induced regulation of expression networks in neurons is a comprehensive characterisation of matched mRNA and miRNA expression profiles by excluding other cell types. Hence, we acquired mRNA and miRNA profiles at the level of distinct neurons in healthy mice and compared them to mice with experimental autoimmune encephalomyelitis (EAE), the animal model of MS. By taking advantage of novel genetic methods allowed us to directly isolate neuronal mRNAs and miRNAs from inflamed and healthy CNS homogenates. Using next generation sequencing on these neuron-specific mRNA and miRNA isolates gave us a never before acquired quantification of transcript compositions in neurons during CNS inflammation. Notably, the mRNA profiles showed a significant underrepresentation of mitochondrial transcripts in neurons during the EAE model. At the same time these transcripts where predicted to be targets of newly identified inflammation-induced neuronal miRNAs. Therefore, we now propose to further narrow our results by UV crosslinking and immunoprecipitation of mRNA targets together with their miRNAs specifically from neurons to reveal direct interaction sites. In order to functionally characterise the impact of an altered composition of miRNAs, we will use in vitro and in vivo studies of the most significantly regulated miRNAs, deciphering their contribution to mitochondrial metabolic function and neuronal preservation or degeneration. Together, this will offer a new approach of understanding miRNA control of mRNA networks that govern mitochondrial function and contribute to neurodegeneration or -protection during CNS inflammation. Understanding the role of miRNAs in the pathophysiologic mechanisms may offer a new therapeutic modality for disease modification.
Willing A, JÃ¤ger J, Reinhardt S, Kursawe N, Friese MA. Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression. J Immunol. 2018 Feb 1;200(3):974-982.
Ufer F, Vargas P, Engler JB, Tintelnot J, Schattling B, Winkler H, Bauer S, Kursawe N, Willing A, Keminer O, Ohana O, Salinas-Riester G, Pless O, Kuhl D, Friese MA. Arc/Arg3.1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activation. Sci Immunol. 2016 Sep 23;1(3):eaaf8665.
Engler JB, Kursawe N, Solano ME, Patas K, Wehrmann S, Heckmann N, LÃ¼hder F, Reichardt HM, Arck PC, Gold SM, Friese MA. Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy. Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E181-E190.
Schattling B, Fazeli W, Engeland B, Liu Y, Lerche H, Isbrandt D, Friese MA. Activity of Na(V)1.2 promotes neurodegeneration in an animal model of multiple sclerosis. JCI Insight. 2016 Nov 17;1(19):e89810.
Schattling B, Steinbach K, Thies E, Kruse M, Menigoz A, Ufer F, Flockerzi V, BrÃ¼ck W, Pongs O, Vennekens R, Kneussel M, Freichel M, Merkler D, Friese MA. TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2012 Dec;18(12):1805-11.